Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Hôpitaux Universitaires de Genève (HUG)

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

Hôpitaux Universitaires de Genève (HUG) is the largest university hospital group in Switzerland and ranked among the top 20 hospitals worldwide in Newsweek’s 2026 global rankings. Established in 1995 through the merger of Geneva’s public sector hospitals, HUG operates as a sprawling network comprising 11 hospital sites and dozens of outpatient care centers throughout the Canton of Geneva. Affiliated with the Faculty of Medicine of the University of Geneva, HUG coordinates cutting-edge medical research and clinical care across various domains, featuring the largest maternity ward in Switzerland and an acclaimed center for organ transplantation. Notably, HUG is recognized by the World Health Organization (WHO) as a center of excellence in telemedicine and vaccinology and was the first hospital in Europe to achieve international Healthcare Sustainability Certification.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. University hospital

Business Subcategory

Source: Human-provided. University hospital
Source: Human-provided. General hospital
Source: Human-provided. Hospital department
Source: Trial-derived.
100Total Trials
Source: Trial-derived.
24Recruiting Trials
Source: Trial-derived.
49Active Trials
Source: Trial-derived.
33Completed Trials
Source: Trial-derived.
168Unique Conditions
Source: Trial-derived.
119Unique Sponsors

Conditions

Source: Trial-derived. Cancer (3)Source: Trial-derived. COVID-19 (3)Source: Trial-derived. Pulmonary Embolism (3)Source: Trial-derived. ADHD (2)Source: Trial-derived. Cartilage Repair (2)Source: Trial-derived. Childhood Cancer (2)Source: Trial-derived. Deep Venous Thrombosis (2)Source: Trial-derived. Fertility Disorders (2)

Sponsors

Source: Trial-derived. University Hospital, Geneva (20)Source: Trial-derived. Insel Gruppe AG, University Hospital Bern (8)Source: Trial-derived. Hoffmann-La Roche (7)Source: Trial-derived. European Organisation for Research and Treatment of Cancer - EORTC (5)Source: Trial-derived. Bayer (4)Source: Trial-derived. Hôpital du Valais (4)Source: Trial-derived. Merck Sharp & Dohme LLC (4)Source: Trial-derived. Swiss National Science Foundation (4)

Facilities & Operations

Facilities and operational capabilities inferred from trial participation

Source: AI-inferred. Overnight or inpatient research stays supported

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. CT Scan
Source: AI-inferred. Continuous glucose monitoring
Source: AI-inferred. MRI
Source: AI-inferred. Echocardiography
Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. Full pulmonary function lab (DLCO / plethysmography)
Source: AI-inferred. PET-CT
Source: AI-inferred. SPECT / nuclear medicine

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Biobanking
Source: AI-inferred. Flow Cytometry
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. PCR / molecular

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Cardiac catheterisation or electrophysiology procedures
Source: AI-inferred. Liver biopsy
Source: AI-inferred. Peripheral angiography and endovascular intervention
Source: AI-inferred. Radiation therapy
Source: AI-inferred. Radiopharmaceutical handling and administration
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. CD4+ T-cell count testing
Source: AI-inferred. HIV-1 genotypic and phenotypic drug resistance testing
Source: AI-inferred. Hepatic portal vein cell infusion
Source: AI-inferred. Liver transplantation programme
Source: AI-inferred. Mixed-meal tolerance test
Source: AI-inferred. Radioembolization dosimetry software analysis (Simplicit90Y)
Source: AI-inferred. Transcatheter aortic valve replacement (TAVR)